On a rebound, is Sonic Healthcare offering an investment opportunity?
Sonic Healthcare has formed a strong base for a potential rally ahead backed by improved operations, expanding margins and synergies from LADR acquisition.
Sonic Healthcare Limited (ASX: SHL)
is a global provider of medical diagnostic services with a current market capitalisation of $11.5 billion.
The company’s laboratory division delivers pathology and clinical laboratory services across many countries which forms the core revenue base.
FY25 statutory revenue reached $9.65 billion which was primarily driven by organic growth.
Net profit for FY25 rose 7% to $514 million while operating cash flow increased 21% to $1.3 billion which reflects stronger operational momentum.
Sonic Healthcare achieved a 40 bps normalised EBITDA margin expansion in FY25 driven by higher specialised testing volumes and operational scale efficiencies.
The company also aims efficiency gains through laboratory automation, digital pathology and AI adoption which are expected to support margin expansion and return on invested capital.
The company completed the acquisition of LADR in Germany which contributes €370 million in revenue and strengthens Sonic’s European presence.
Management expects the LADR transaction to be immediately EPS accretive and to deliver a post synergy after tax return on investment above 11% within three years.
Sonic maintains a conservative financial position with gearing at 24.7% and interest cover of 10.1x which indicates strong balance sheet stability.
The total FY25 dividends amounted to $1.07 per share which were paid on a semi-annual basis and the stock currently provides an annual yield of 4.6%.
The company trades at a P/E ratio of 21.8 and a Price/Free Cash Flow ratio of 8.45 while long-term growth is supported by ageing populations and rising demand for complex diagnostics.
Sonic reaffirmed FY26 EBITDA guidance of $1.87 to $1.95 billion implying up to 13% growth on a constant currency basis with catalysts including LADR integration benefits, specialised testing margin expansion and continued earnings growth.
(Source: Company Announcements)
Get Your Free Report on Top 5 ASX Stocks on WhatsApp
Instant Access. No Credit Card Required.
Receive on WhatsApp
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialASX Stock Research & Recommendations — 7‑day free trial
Independent, analyst‑driven insights.
- Stock of the week report
- Daily Analysis Report
- No credit card required
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Article
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
